Santen, Arctic Vision sign deal for ARVN001 to treat UME

Santen Pharmaceutical and Arctic Vision have signed a commercial collaboration agreement for the ARVN001to treat uveitic macular oedema.

Nov 9, 2024 - 06:00

Santen, Arctic Vision sign deal for ARVN001 to treat UME

Santen Pharmaceutical and Arctic Vision have signed a commercial collaboration agreement for the ARVN001to treat uveitic macular oedema.

Read the original article

Tags:

Previous Article

Sonnet BioTherapeutics secures US patent covering two drug candidates

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Vedanta Biosciences raises funds to advance defined bacterial consortia therapies

Vedanta Biosciences raises funds to advance defined bac...

Apr 26, 2023

STAT+: Medicare slashes safety net hospital payments on estimate that more people have insurance

STAT+: Medicare slashes safety net hospital payments on...

Aug 5, 2023

Opinion: The apparent poisoning of schoolgirls is just one part of Iran’s health crisis

Opinion: The apparent poisoning of schoolgirls is just ...

May 1, 2023